These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 37268109)
21. Effects of Sub-Minimum Inhibitory Concentrations of Imipenem and Colistin on Expression of Biofilm-Specific Antibiotic Resistance and Virulence Genes in Shenkutie AM; Zhang J; Yao M; Asrat D; Chow FWN; Leung PHM Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293559 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii. Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789 [TBL] [Abstract][Full Text] [Related]
23. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii - a global health menace. Rai S; Kumar A Environ Microbiol Rep; 2022 Jun; 14(3):347-364. PubMed ID: 34196126 [TBL] [Abstract][Full Text] [Related]
24. Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains. Chen LK; Kuo SC; Chang KC; Cheng CC; Yu PY; Chang CH; Chen TY; Tseng CC Sci Rep; 2017 Jul; 7(1):6319. PubMed ID: 28740225 [TBL] [Abstract][Full Text] [Related]
25. Antibiotics Act with vB_AbaP_AGC01 Phage against Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645 [TBL] [Abstract][Full Text] [Related]
26. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens. Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591 [TBL] [Abstract][Full Text] [Related]
27. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994 [TBL] [Abstract][Full Text] [Related]
28. Phage-antibiotic combinations against multidrug-resistant Holger DJ; El Ghali A; Bhutani N; Lev KL; Stamper K; Kebriaei R; Kunz Coyne AJ; Morrisette T; Shah R; Alexander J; Lehman SM; Rojas LJ; Marshall SH; Bonomo RA; Rybak MJ Antimicrob Agents Chemother; 2023 Nov; 67(11):e0057823. PubMed ID: 37855639 [TBL] [Abstract][Full Text] [Related]
29. Lysin LysMK34 of Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718 [TBL] [Abstract][Full Text] [Related]
30. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477 [TBL] [Abstract][Full Text] [Related]
31. Stability study in selected conditions and biofilm-reducing activity of phages active against drug-resistant Acinetobacter baumannii. Bagińska N; Grygiel I; Orwat F; Harhala MA; Jędrusiak A; Gębarowska E; Letkiewicz S; Górski A; Jończyk-Matysiak E Sci Rep; 2024 Feb; 14(1):4285. PubMed ID: 38383718 [TBL] [Abstract][Full Text] [Related]
32. Isolation of virulent phages against multidrug-resistant Acinetobacter baumannii recovered from inanimate objects of Jimma Medical Center, Southwest Ethiopia. Hailemichael T; Girma L; Fissiha P; Geteneh A; Kassa T BMC Infect Dis; 2023 Nov; 23(1):820. PubMed ID: 37993809 [TBL] [Abstract][Full Text] [Related]
33. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377 [TBL] [Abstract][Full Text] [Related]
34. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii. Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881 [TBL] [Abstract][Full Text] [Related]
36. Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage infecting multidrug-resistant Acinetobacter baumannii clinical strains. Zhang Y; Shao Y; You H; Shen Y; Miao F; Yuan C; Chen X; Zhai M; Shen Y; Zhang J Virology; 2024 Jul; 595():110098. PubMed ID: 38705084 [TBL] [Abstract][Full Text] [Related]
37. Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection. Ghaznavi-Rad E; Komijani M; Moradabadi A; Rezaei M; Shaykh-Baygloo N J Clin Lab Anal; 2022 Jul; 36(7):e24497. PubMed ID: 35708005 [TBL] [Abstract][Full Text] [Related]
38. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro. Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011 [TBL] [Abstract][Full Text] [Related]
39. Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination. Sato Y; Ubagai T; Tansho-Nagakawa S; Yoshino Y; Ono Y Sci Rep; 2021 Jun; 11(1):11700. PubMed ID: 34083569 [TBL] [Abstract][Full Text] [Related]